20.06 14:54 | dpa-AFX: Thermo Fisher Extends Expiration Of Tender Offer For Olink Shares, ADSs |
20.06 14:12 | dpa-AFX: *THERMO FISHER SCIENTIFIC EXTENDS TENDER OFFER DEADLINE FOR OLINK SHARES AND ADSS TO JULY 9 |
04.06 07:26 | dpa-AFX: *JEFFERIES HEBT THERMO FISHER SCIENTIFIC AUF 'BUY' (HOLD) - ZIEL 650 (600) USD |
04.06 07:26 | dpa-AFX: *JEFFERIES RAISES THERMO FISHER SCIENTIFIC TO 'BUY' (HOLD) - PRICE TARGET 650 (600) USD |
22.05 23:37 | dpa-AFX: *THERMO FISHER SCIENTIFIC (TMO) DECLARES QUARTERLY DIVIDEND OF $ 0.39 , RECORD DATE 6/14/2024 |
01.05 14:06 | dpa-AFX: *THERMO FISHER SCIENTIFIC EXTENDS EXPIRATION OF TENDER OFFER FOR COMMON SHARES AND ADSS OF OLINK TO JUNE 18, 2024 |
24.04 13:31 | dpa-AFX: Thermo Fisher Scientific Q1 24 Earnings Conference Call At 8:30 AM ET |
24.04 12:27 | dpa-AFX: ROUNDUP: Thermo Fisher Lifts FY24 Earnings, Sales View; Stock Up In Pre-market |
24.04 12:15 | dpa-AFX: *THERMO FISHER SCIENTIFIC LIFTS FY ADJ EPS GUIDANCE TO A NEW RANGE OF $21.14 TO $22.02 |
24.04 12:14 | dpa-AFX: *THERMO FISHER SCIENTIFIC LIFTS FY REVENUE GUIDANCE TO A NEW RANGE OF $42.3 BLN TO $43.3 BLN |
24.04 12:13 | dpa-AFX: *THERMO FISHER SCIENTIFIC Q1 REVENUE $10.34 BLN VS $10.71 BLN LAST YEAR |
24.04 12:08 | dpa-AFX: Thermo Fisher Scientific Q1 Profit Increases, beats estimates |
24.04 12:03 | dpa-AFX: *THERMO FISHER Q1 GAAP EPS UP 4% TO $3.46; ADJ EPS UP 2% TO $5.11 |
20.03 14:30 | Bayer und Thermo Fisher kooperieren in der Präzisionsonkologie |
20.03 14:14 | dpa-AFX: *BAYER UND THERMO FISHER SCIENTIFIC MIT ZUSAMMENARBEIT IN PRÄZISIONSONKOLOGIE |
01.03 14:59 | dpa-AFX: Thermo Fisher Extends Acquisition Deadline For Olink Until April 30 |
01.03 14:07 | dpa-AFX: *THERMO FISHER SCIENTIFIC EXTENDS TENDER OFFER FOR OLINK UNTIL APRIL 30 |
21.02 23:04 | dpa-AFX: *THERMO FISHER SCIENTIFIC (TMO) DECLARES QUARTERLY DIVIDEND OF $ 0.39, RECORD DATE 3/15/2024 |
31.01 13:30 | dpa-AFX: Thermo Fisher Scientific Q4 23 Earnings Conference Call At 8:30 AM ET |
31.01 12:16 | dpa-AFX: Thermo Fisher Scientific Q4 Profit Up, Beats Estimates; Sees FY24 Adj. EPS Below Market |
|